Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Syno Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$43M
Portfolio companies 5
Rounds per year 0.67
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 2
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Personal Health
Summary

In 2015 was created Syno Capital, which is appeared as VC. The main office of represented VC is situated in the New York. The venture was found in North America in United States.

The overall number of key employees were 2.

Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015. The fund is constantly included in less than 2 deals per year. This Syno Capital works on 4 percentage points more the average amount of lead investments comparing to the other organizations.

Among the most popular portfolio startups of the fund, we may highlight ORIG3N, Honor, Cynvenio Biosystems. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Pharmaceutical. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.

The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Syno Capital, startups are often financed by Hatteras Venture Partners, Mountain Group Capital, 180 Degree Capital. The meaningful sponsors for the fund in investment in the same round are Hatteras Venture Partners, Mountain Group Capital, LabCorp. In the next rounds fund is usually obtained by Spectrum Health Ventures, LabCorp, Hatteras Venture Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Syno Capital:
Typical Co-investors
Syno Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Syno Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Autodesk Foundation California, San Francisco, United States
Chivas Venture England, London, United Kingdom
DC Thomson Ventures England, London, United Kingdom
Fuhui Yida Keji Beijing, Beijing, China
Ghawi Capital LLC -
GSV AcceleraTE California, San Francisco, United States
Hongtai Capital Holdings Beijing, Beijing, China
JSM Capital British Columbia, Canada, Vancouver
Launchpad -
Mic Finance China, Shanghai
National Digital Infrastructure Fund England, London, United Kingdom
NewSchools Venture Fund California, Oakland, United States
ReumaNederland -
Spencer Energy AS -
Stonehenge NYC New York, New York, United States
Timeline Ventures California, San Diego, United States
Ulupono Initiative Hawaii, Honolulu, United States
Vespa Capital England, London, United Kingdom
Wenshi Touzi China, Shanghai
YaraGerminate Norway, Oslo

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

TCR2

Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Therapeutics
$125M21 Mar 2018 Cambridge, Massachusetts, United States

Health Care
Home Health Care
Recruiting
Scheduling
Wellness
$45M05 Aug 2016 San Francisco, California, United States

ORIG3N

Biotechnology
Health Care
Medical
Personal Health
$12M12 Dec 2015 Boston, Massachusetts, United States

LungLife AI

Artificial Intelligence
Biotechnology
Health Diagnostics
Machine Learning
Medical
$25M17 Jun 2015 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Syno Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 43M
Rounds per year 0.67
Peak activity year 2018
Lead investments 0
Follow on index 0.17
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

TCR2

Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Therapeutics
$125M21 Mar 2018 Cambridge, Massachusetts, United States

Health Care
Home Health Care
Recruiting
Scheduling
Wellness
$45M05 Aug 2016 San Francisco, California, United States

ORIG3N

Biotechnology
Health Care
Medical
Personal Health
$12M12 Dec 2015 Boston, Massachusetts, United States

LungLife AI

Artificial Intelligence
Biotechnology
Health Diagnostics
Machine Learning
Medical
$25M17 Jun 2015 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: